Peiyu Yan

2.0k total citations · 2 hit papers
46 papers, 989 citations indexed

About

Peiyu Yan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Peiyu Yan has authored 46 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Oncology. Recurrent topics in Peiyu Yan's work include Lung Cancer Treatments and Mutations (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Peiyu Yan is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Peiyu Yan collaborates with scholars based in China, Macao and United States. Peiyu Yan's co-authors include Elaine Lai‐Han Leung, Ying Xie, Qibiao Wu, Xing‐Xing Fan, Zebo Jiang, Jumin Huang, Runze Li, Xiaojun Yao, Jiaxin Li and Chun Xie and has published in prestigious journals such as ACS Nano, PLoS ONE and Energy.

In The Last Decade

Peiyu Yan

44 papers receiving 970 citations

Hit Papers

Luteolin and its derivative apigenin suppress the inducib... 2021 2026 2022 2024 2021 2024 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer
    2021 177 citations Zebo Jiang, Wenjun Wang et al. Cancer Letters profile →
  2. Novel nano-drug delivery system for natural products and their application
    2024 98 citations Peiyu Yan, Ying Xie et al. Pharmacological Research profile →

Peers

Peiyu Yan
Hudan Pan China
Ying Cheng China
Huan Zhou China
Senyi Deng China
Rajan Radha Rasmi India
Jianyu Feng China
Junzhe Zhang China
Yu Huang China
Joon‐Suk Park South Korea
Jingyu Xu China
Hudan Pan China
Peiyu Yan
Citations per year, relative to Peiyu Yan Peiyu Yan (= 1×) peers Hudan Pan

Countries citing papers authored by Peiyu Yan

Since Specialization
Citations

This map shows the geographic impact of Peiyu Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiyu Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiyu Yan more than expected).

Fields of papers citing papers by Peiyu Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peiyu Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiyu Yan. The network helps show where Peiyu Yan may publish in the future.

Co-authorship network of co-authors of Peiyu Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Peiyu Yan. A scholar is included among the top collaborators of Peiyu Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peiyu Yan. Peiyu Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yan, Peiyu, et al.. (2025). Efficacy of Auricular Therapy for Motor Impairment After Stroke: A Systematic Review and Meta‐Analysis. International Journal of Older People Nursing. 20(1). e70006–e70006.
3.
Zhang, Weizheng, Xiangsheng Cai, Lin Lü, et al.. (2025). A study on the correlation between hyperuricemia and lifestyle and dietary habits. Medicine. 104(5). e41399–e41399. 1 indexed citations
4.
Chen, Yan, Fengsheng Chen, Lishan Chen, et al.. (2024). Oroxylin A suppresses breast cancer-induced osteoclastogenesis and osteolysis as a natural RON inhibitor. Phytomedicine. 129. 155688–155688. 7 indexed citations
5.
Liang, Tu-Liang, Hudan Pan, Peiyu Yan, et al.. (2024). Serum taurine affects lung cancer progression by regulating tumor immune escape mediated by the immune microenvironment. Journal of Advanced Research. 73. 427–442. 7 indexed citations
6.
Huang, Li, Xi Yang, Yi Feng, et al.. (2024). ShaShen-MaiDong decoction attenuates bleomycin-induced pulmonary fibrosis by inhibiting TGF-β/smad3, AKT/MAPK, and YAP/TAZ pathways. Journal of Ethnopharmacology. 337(Pt 1). 118755–118755. 5 indexed citations
7.
Yang, Jia, Qihui Sun, Xiaoyun Liu, et al.. (2024). Targeting Notch signaling pathways with natural bioactive compounds: a promising approach against cancer. Frontiers in Pharmacology. 15. 1412669–1412669. 5 indexed citations
8.
Chen, Qi, Chengyuan Wu, Siwei Wang, et al.. (2023). Glycyrrhizic acid modified Poria cocos polyscaccharide carbon dots dissolving microneedles for methotrexate delivery to treat rheumatoid arthritis. Frontiers in Chemistry. 11. 1181159–1181159. 19 indexed citations
9.
Yan, Peiyu, et al.. (2023). Sinomenine hydrochloride bidirectionally inhibits progression of tumor and autoimmune diseases by regulating AMPK pathway. Phytomedicine. 114. 154751–154751. 20 indexed citations
10.
Chen, Qiuxin, et al.. (2023). Age-Related Alterations in Immune Function and Inflammation: Focus on Ischemic Stroke. Aging and Disease. 15(3). 1046–1074. 17 indexed citations
11.
Chen, Xiangru, Peiyu Yan, Wenqiang Zhang, et al.. (2022). Bioengineered polyester nanoparticles for the synergistic treatment of androgenic alopecia via the suppression of 5α-reductase and knockdown of androgen receptor. Frontiers in Bioengineering and Biotechnology. 10. 1033987–1033987. 5 indexed citations
12.
Li, Jiaxin, Runze Li, Peng Wang, et al.. (2022). Targeting Mutant Kirsten Rat Sarcoma Viral Oncogene Homolog in Non-Small Cell Lung Cancer: Current Difficulties, Integrative Treatments and Future Perspectives. Frontiers in Pharmacology. 13. 875330–875330. 10 indexed citations
13.
Jiang, Zebo, Wenjun Wang, Cong Xu, et al.. (2021). Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancer. Cancer Letters. 515. 36–48. 177 indexed citations breakdown →
14.
15.
Liang, Tu-Liang, Runze Li, Chu-Tian Mai, et al.. (2021). A method establishment and comparison of in vivo lung cancer model development platforms for evaluation of tumour metabolism and pharmaceutical efficacy. Phytomedicine. 96. 153831–153831. 7 indexed citations
16.
Jiang, Zebo, Cong Xu, Wenjun Wang, et al.. (2021). Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells. Pharmacological Research. 169. 105656–105656. 33 indexed citations
17.
Wang, Lizhen, et al.. (2020). Intradermal acupuncture for primary dysmenorrhea. Medicine. 99(37). e22188–e22188. 4 indexed citations
18.
Xie, Ying, Wei-Yu Meng, Runze Li, et al.. (2020). Early lung cancer diagnostic biomarker discovery by machine learning methods. Translational Oncology. 14(1). 100907–100907. 147 indexed citations
19.
Yan, Peiyu. (2013). Nitrous Oxide Emissions and Its Influencing Factors in Spring Corn Fields Mulched with Plastic Film on the Loess Plateau. Nongye huanjing kexue xuebao. 2 indexed citations
20.
Wang, Yaxian, Haijiao Wang, Peiyu Yan, Xiaohong Yu, & Jianzhi Li. (2012). Application of new tumor marker, angiopoietin-2 detections in diagnosis of lung cancer. 35(2). 160–162. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hudan Pan Breakdown of academic impact, for papers by Ying Cheng Breakdown of academic impact, for papers by Huan Zhou Breakdown of academic impact, for papers by Senyi Deng Breakdown of academic impact, for papers by Rajan Radha Rasmi Breakdown of academic impact, for papers by Jianyu Feng Breakdown of academic impact, for papers by Junzhe Zhang Breakdown of academic impact, for papers by Yu Huang Breakdown of academic impact, for papers by Joon‐Suk Park Breakdown of academic impact, for papers by Jingyu Xu
Rankless by CCL
2026